These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12796025)

  • 21. Expression and distribution of c-kit receptor and its ligand in human CNS germ cell tumors: a useful histological marker for the diagnosis of germinoma.
    Takeshima H; Kaji M; Uchida H; Hirano H; Kuratsu J
    Brain Tumor Pathol; 2004; 21(1):13-6. PubMed ID: 15696963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas.
    Fukushima S; Otsuka A; Suzuki T; Yanagisawa T; Mishima K; Mukasa A; Saito N; Kumabe T; Kanamori M; Tominaga T; Narita Y; Shibui S; Kato M; Shibata T; Matsutani M; Nishikawa R; Ichimura K;
    Acta Neuropathol; 2014; 127(6):911-25. PubMed ID: 24452629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. c-kit gene mutations in intracranial germinomas.
    Sakuma Y; Sakurai S; Oguni S; Satoh M; Hironaka M; Saito K
    Cancer Sci; 2004 Sep; 95(9):716-20. PubMed ID: 15471556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors.
    Looijenga LH; de Leeuw H; van Oorschot M; van Gurp RJ; Stoop H; Gillis AJ; de Gouveia Brazao CA; Weber RF; Kirkels WJ; van Dijk T; von Lindern M; Valk P; Lajos G; Olah E; Nesland JM; Fosså SD; Oosterhuis JW
    Cancer Res; 2003 Nov; 63(22):7674-8. PubMed ID: 14633689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors.
    Nakai Y; Nonomura N; Oka D; Shiba M; Arai Y; Nakayama M; Inoue H; Nishimura K; Aozasa K; Mizutani Y; Miki T; Okuyama A
    Biochem Biophys Res Commun; 2005 Nov; 337(1):289-96. PubMed ID: 16188233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of gene mutations in KIT-positive thymic epithelial tumors.
    Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
    Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors.
    Koul S; McKiernan JM; Narayan G; Houldsworth J; Bacik J; Dobrzynski DL; Assaad AM; Mansukhani M; Reuter VE; Bosl GJ; Chaganti RS; Murty VV
    Mol Cancer; 2004 May; 3():16. PubMed ID: 15149548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of VEGF-A/C, VEGF-R2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma.
    Brunner M; Thurnher D; Pammer J; Geleff S; Heiduschka G; Reinisch CM; Petzelbauer P; Erovic BM
    Mod Pathol; 2008 Jul; 21(7):876-84. PubMed ID: 18408656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and prognostic value of the lung resistance-related protein (LRP) in germ cell testicular tumors.
    Mándoky L; Géczi L; Doleschall Z; Bodrogi I; Csuka O; Kásler M; Bak M
    Anticancer Res; 2004; 24(2C):1097-104. PubMed ID: 15154630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of protooncogenes in human germ cell tumors of the testis.
    Shuin T; Misaki H; Kubota Y; Yao M; Hosaka M
    Cancer; 1994 Mar; 73(6):1721-7. PubMed ID: 7908857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
    Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
    J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preservation of KIT genotype in a novel pair of patient-derived orthotopic xenograft mouse models of metastatic pediatric CNS germinoma.
    Lindsay H; Huang Y; Du Y; Braun FK; Teo WY; Kogiso M; Qi L; Zhang H; Zhao S; Mao H; Lin F; Baxter P; Su JM; Terashima K; Perlaky L; Chintagumpala M; Adesina A; Lau CC; Williams Parsons D; Li XN
    J Neurooncol; 2016 May; 128(1):47-56. PubMed ID: 26956263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic significance of soluble c-kit in the cerebrospinal fluid of patients with germ cell tumors.
    Miyanohara O; Takeshima H; Kaji M; Hirano H; Sawamura Y; Kochi M; Kuratsu J
    J Neurosurg; 2002 Jul; 97(1):177-83. PubMed ID: 12134909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours.
    Bokemeyer C; Kuczyk MA; Dunn T; Serth J; Hartmann K; Jonasson J; Pietsch T; Jonas U; Schmoll HJ
    J Cancer Res Clin Oncol; 1996; 122(5):301-6. PubMed ID: 8609154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptosis regulation and spontaneous apoptosis index of testicular germ cell tumors are associated with differentiation and resistance to systemic treatment.
    Mandoky L; Szende B; Géczi L; Bodrogi I; Kásler M; Bak M
    Anticancer Res; 2008; 28(3A):1641-9. PubMed ID: 18630521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.
    Sanmamed MF; Esteban E; Uriol E; Zarate R; Capelan M; Muriel C; Crespo G; Berros JP; Pardo-Coto P; Perez Q; Alvarez-Fernández C; Jiménez Fonseca P; Luque M; Astudillo A
    J Transl Med; 2017 Mar; 15(1):62. PubMed ID: 28320414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic evolution and chemoresistance in germ-cell tumours.
    Taylor-Weiner A; Zack T; O'Donnell E; Guerriero JL; Bernard B; Reddy A; Han GC; AlDubayan S; Amin-Mansour A; Schumacher SE; Litchfield K; Turnbull C; Gabriel S; Beroukhim R; Getz G; Carter SL; Hirsch MS; Letai A; Sweeney C; Van Allen EM
    Nature; 2016 Nov; 540(7631):114-118. PubMed ID: 27905446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P53, bcl-2 and bax immunoreactivity as predictors of response and outcome after chemotherapy for metastatic germ cell testicular tumours.
    Baltaci S; Orhan D; Türkölmez K; Yesilli C; Bedük Y; Tulunay O
    BJU Int; 2001 May; 87(7):661-6. PubMed ID: 11350408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predominant expression of fibroblast growth factor (FGF) 8, FGF4, and FGF receptor 1 in nonseminomatous and highly proliferative components of testicular germ cell tumors.
    Suzuki K; Tokue A; Kamiakito T; Kuriki K; Saito K; Tanaka A
    Virchows Arch; 2001 Nov; 439(5):616-21. PubMed ID: 11764380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
    Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
    Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.